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Candida pathogenesis: Unravelling the threads of infection
Brian E. Corner and P.T. Magee
Recent studies are beginning to delineate those
pathways by which the important pathogen Candida
albicans switches from one growth form to another; at
the same time, insights are being gained into the
importance of growth form in pathogenesis.
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As countless women around the world will testify, the
yeast Candida albicans is a source of recurrent misery in the
form of vaginal candidiasis. Many more of us carry C. albi-
cans within our bodies without its leading to any well doc-
umented problems. What are the factors that lead to this
opportunistic pathogen becoming invasive and frankly
pathogenic? Host factors undoubtedly play a role, as
immunocompromised patients, such as those suffering
from AIDS or undergoing chemotherapy, are frequently
stricken with serious Candida infections, often systemic.
Yet Candida certainly has its own strategies that allow it to
maintain itself within the body and become an aggressive
pathogen under favorable conditions. The identification
of those strategies has become a major research goal, not
only in order to understand and possibly control Candida
infection per se, but also as a means of gaining insights into
the general ways in which other fungal pathogens might
interact with their human hosts.
One of the most remarkable aspects of C. albicans biology
is its ability to assume a variety of cell morphologies
(Figure 1). These range from yeast-like cells to a variety of
elongated growth forms, including a thread-like hyphal
growth form, germ tubes — during the transition between
yeast and hyphae — and pseudohyphae, which vary in
shape from attached strings of yeast-like cells to long fila-
ments with constrictions at the septa. The yeast form is
the one commonly found in the laboratory; the transition
to elongated growth is promoted by a wide range of envi-
ronmental conditions, including growth at 37°C, exposure
to serum or a neutral pH. 
It has long been suspected that this polymorphism is an
important facet of C. albicans pathogenesis, although it has
not been clear whether it is any one growth form that is
required for infection, or whether simply having the
potential for phenotypic plasticity is important. Two
recent studies [1,2] have finally provided some strong
experimental support for the notion that the capacity for
hyphal formation is critical for Candida pathogenesis, at
least in a mouse model, while another study [3] promises
to answer the complementary question of whether yeast
phase growth is also required for Candida infection.
Proof that a molecule or a property is a virulence factor has
generally relied on genetic strategies in which mutants are
generated and virulence compared with otherwise isogenic
wild-type strains. For C. albicans this is far from simple, as
the organism is diploid and lacks a sexual cycle. Genetic
analysis has been made more tractable through the devel-
opment of transformation and sequential gene disruption
procedures that employ reusable gene cassettes. Nonethe-
less, many previous attempts to demonstrate C. albicans vir-
ulence factors can be criticized on the grounds that, although
they may have demonstrated reduced virulence of a mutant
derivative with respect to the parental strain, they failed to
demonstrate restoration of full virulence when the wild-
type gene is reintroduced into the mutant. Thus, changes
in virulence might have occurred simply through accumula-
tion of undetected (and undesired) changes during the mul-
tiple steps required to inactivate the two copies (or more in
the case of gene families) of the target gene.
These criticisms have largely been dealt with in the paper
by Leberer and colleagues [1], and they provide convincing
Figure 1
Candida albicans can assume a variety of morphologies. The
photograph shows C. albicans growing as yeast (Y), pseudohyphal (P)
or hyphal (H) forms after prolonged growth in liquid medium.
evidence that hypha formation is required for C. albicans
infection in a model in which mice are infected intra-
venously with yeast cells. They followed a strategy that is
rapidly becoming the norm for Candida studies, in which
our ever-increasing knowledge about the related non-path-
ogenic — but far more genetically tractable — yeast Saccha-
romyces cerevisiae is used to formulate educated guesses
about mechanisms that are likely to operate in C. albicans.
Candida genes relevant to the current discussion of mor-
phogenesis, and their Saccharomyces counterparts are listed
in Table 1. Leberer and colleagues [1] reasoned that
members of the Ste20 family of serine/threonine protein
kinases, which are involved in triggering morphogenetic
processes in a wide range of organisms, are excellent
candidate regulators of C. albicans morphogenesis. 
In a previous study, Leberer and colleagues [4] disrupted
the C. albicans STE20 homolog CST20 and showed that,
although the strain was impaired for morphogenesis under
some induction conditions, it was still capable of forming
hyphae in serum at 37°C. The virulence of the cst20
mutants, assessed in a mouse model, was reduced, but not
completely eliminated. This led them to focus their atten-
tion on the other well characterized member of the STE20
family in S. cerevisiae, CLA4 [1]. 
When both copies of the C. albicans CLA4 gene were
disrupted, the mutants were unable to form hyphae under a
wide range of induction conditions, including incubation in
serum at 37°C. Leberer and colleagues [1] further demon-
strated that the cla4 mutant is avirulent in a mouse model.
And significantly, virulence was restored to the mutant
strain by transformation with a plasmid bearing a functional
version of CLA4. Although it is still possible that a function
of CLA4 other than in morphogenesis is required for infec-
tion, the unaffected growth rate of the mutant when grown
under laboratory conditions provides a strong argument
that it is not grossly impaired for general cellular processes.
In addition to its contribution to our understanding of the
role of hyphae in pathogenesis, this paper [1] is important
because it demonstrates that plasmids can be used to
restore the wild-type phenotype of C. albicans mutants in
vivo. As the plasmids presently available for use in C. albi-
cans are relatively unstable, investigators have hesitated to
use them in virulence experiments. Leberer and coworkers
[1] have shown that this approach is a feasible one, open-
ing the door to a more vigorous testing of the virulence
properties of isolated genes.
How might CLA4 be involved in the dimorphic transition
of C. albicans, and what are some of the other key players
in C. albicans morphogenesis? As mentioned above, CLA4
encodes a member of the Ste20 family of proteins. In S.
cerevisiae, Ste20 proteins are known to participate in the
mitogen-activated protein (MAP) kinase pathway, which
is required for pseudohyphal induction in response to
nitrogen starvation. Two other C. albicans genes that act in
this pathway have now been identified — HST7 and
CPH1/ACPR, homologs of S. cerevisiae genes STE7 and
STE12, respectively — and mutants lacking those func-
tions have been generated [4–6]. These mutants resem-
bled the cst20 mutant, in that they showed impaired
hyphal induction only under certain conditions and were
able to form hyphae in serum at 37°C, possibly indicating
that more than one pathway can lead to hyphal formation
in Candida. 
Additional support for the concept of parallel pathways
leading to hyphal formation comes from an analysis of cph1
efg1 double mutants [2]. EFG1 was first detected in a
screen for Candida genes that cause enhanced filamentous
growth when overexpressed in S. cerevisiae [7]. The EFG1
protein sequence suggests that it is a Myc-like transcrip-
tion factor with a basic helix–loop–helix motif [7]. EFG1 is
also similar to three other fungal genes implicated in mor-
phogenesis: StuA of Aspergillus nidulans, which is required
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Table 1
Summary of Candida albicans genes involved in the regulation of morphogenesis.
Candida gene Saccharomyces counterpart Mutant phenotype Putative function Reference
CLA4 CLA4 Unable to form hyphae under all Protein kinase in MAP [1]
conditions tested; avirulent kinase cascade
CST20 STE20 Partial defect in hyphae formation; Protein kinase in MAP [4,6]
reduced virulence kinase cascade
HST7 STE7 Partial defect in hyphae formation; Protein kinase in MAP [4,6]
reduced virulence kinase cascade
CPH1 STE12 Partial defect in hyphae formation; Transcription factor regulated [5]
reduced virulence by MAP kinase cascade
TUP1 TUP1 Constitutive hyphal formation Transcriptional repressor [3]
EFG1 PHD1/SOK2 Forms pseudohyphae, unable Transcriptional activator [2,7]
to form true hyphae, reduced virulence and repressor
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at several different developmental stages [8], and PHD1
and SOK2 of S. cerevisiae. Like EFG1, PHD1 is an enhancer
of filamentation in S. cerevisiae, whereas SOK2 inhibits fila-
mentation. Candida efg1 mutants were observed to form
abundant pseudohyphae, but not hyphae, in response to
serum [2]. The double mutant cph1 efg1, however, failed to
produce germ tubes and hyphae under any conditions
tested [2], a phenotype reminiscent of the cla4 mutant. 
Like the non-filamentous cla4 mutant, the cph1 efg1 double
mutant was avirulent at an inoculum size that with the
wild-type strain killed 50% of mice six days after injection.
At higher inoculum levels, the cph1 efg1 double mutant
showed greatly attenuated virulence. Furthermore, the
double mutant showed a profound defect in its response to
phagocytosis by a macrophage-like cell line. Whereas wild-
type Candida responds to phagocytosis with a rapid switch
to the hyphal growth form that leads to piercing of the
macrophage from within, the double mutant remains in
the yeast form, and the macrophage continues to ingest
further yeast cells without any apparent ill-effects. 
The cph1 and efg1 single mutants were each virulent in the
mouse model and exhibited hyphal formation in response
to phagocytosis, although the efg1 mutant was noticeably
impaired in both processes. One of us recently proposed a
model for pseudohypha formation that put CPH1 and EFG1
in the same pathway [9]. This aspect of the model is ren-
dered considerably less likely by the results of Lo et al. [2].
It is more likely that CPH1 and EFG1 act in separate, but
parallel, pathways that lead to hyphal induction, and it is
only when both pathways are eliminated that hyphal induc-
tion is completely abolished. Consistent with this model,
CLA4 might be a common element in both pathways.
A puzzling contradiction between the results of Lo et al.
[2] and those of Stoldt et al. [7] is that the latter group was
unable to generate a homozygous disruption of efg1 and
concluded that this gene might be essential. In principle,
there are several possible reasons for this discrepancy, but
some are very unlikely. For example, Stoldt et al. [7] were
able to disrupt one allele, so it is unlikely that they had
made a dominant lethal disruption. As they inserted ADE2
into the EFG1 gene, they probably did not disrupt an
adjacent gene. Lo et al. [2] did not remove all the coding
region of EFG1, so they may have had some residual activ-
ity. Finally, there may be strain differences; although the
two strains used — CAI4 by Lo et al. [2] and CAI8 by
Stoldt et al. [7] — are closely related, they are not isogenic.
Resolving the question of whether EFG1 is an essential
gene is certainly important in elucidating the pathways in
which it is involved.
If, as it appears, hyphal growth is a requirement for effi-
cient Candida infection in the mouse model, can we say
anything about the role of yeast phase growth in infection?
One way to address this question would be to examine
the virulence of a strain unable to grow in the yeast form.
A strain with such a phenotype was described recently by
Braun and Johnson [3], who found that deletion of C.
albicans TUP1 leads to constitutive hyphal formation. In
S. cerevisiae, Tup1 protein acts as a transcriptional repres-
sor, and tup1 mutants show pleiotropic phenotypes, most
of which can be complemented by overexpression of the
C. albicans TUP1. This argues that the TUP1 function is
highly conserved between the two species, even to the
level of its interactions with the DNA-binding proteins
that are thought to enable TUP1 to repress selected sub-
sets of genes. In S. cerevisiae, elimination of TUP1 activity
does not lead to constitutive pseudohyphal growth;
rather, it decreases the propensity for strains to form
pseudohyphae under nitrogen starvation conditions. The
differences in TUP1 activity between the two species are
presumably due to differences either in the regulation of
the DNA-binding proteins with which Tup1 interacts, or
in the subset of genes that are regulated by Tup1
complexes.
It appears that, in C. albicans, TUP1 plays a central role in
morphogenesis, as the tup1 mutant grows as hyphae or
pseudohyphae under all conditions so far examined. The
tup1 genotype appears incompatible with the yeast growth
form, a more extreme phenotype than has been observed
for other mutants that show partially constitutive hyphal
growth. Significantly, tup1 cph1 double mutants show the
tup1 phenotype, suggesting that TUP1 acts downstream of
CPH1. An attractive model is that multiple input signals
converge on the set of genes involved in pseudohyphal or
hyphal growth, which are negatively regulated by TUP1.
Some of these genes might include repressors of the yeast
growth phase. As to whether the constitutively hyphal
tup1 mutant is pathogenic, at present we must be satisfied
with a tantalizing footnote in which Braun and Johnson
[3] report preliminary data indicating that the tup1 mutant
is far less pathogenic in mice than the parental strain.
They caution, however, that this could be due to defects
unconnected to morphology.
Notwithstanding the differences that are emerging
between S. cerevisiae and Candida morphogenesis, the
strategy of using S. cerevisiae data to guide Candida experi-
ments is clearly a highly productive one. Where is the S.
cerevisiae work now pointing? One obvious area of interest
is that of the role of 14-3-3 proteins, which are found in a
wide range of organisms and have now been shown to
have a role in S. cerevisiae pseudohyphal development [10].
In S. cerevisiae, the 14-3-3 homologs Bmh1 and Bmh2 are
essential for the MAP kinase cascade leading to pseudo-
hyphal development, but not the pheromone-induced
MAP kinase cascade. It is conceivable that the various
pathways leading to hyphal and pseudohyphal develop-
ment in Candida will similarly involve combinatorial
effects of 14-3-3 homologs and other proteins with various
components of the MAP kinase pathway that have already
been identified.
We are faced, then, with weaving together the different
strands of Candida morphogenesis into a tapestry of genetic
interactions and transcription loops. When we have suc-
ceeded in that task, if not before, we can begin the process
of unravelling the tapestry in vivo through use of drugs that
target key enzymes in the hyphal growth pathway. The
Cla4 and Tup1 proteins are worthwhile places to start
searching for inhibitors, and many more possible targets are
sure to follow soon. It will be interesting to see whether
inhibitors that selectively block morphogenetic processes
in Candida offer any advantages over current antifungals
that are fungicidal or fungistatic towards all growth forms of
the organism.
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